Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2011-2023
- HEY1469152
- 87 Pages
- August 2017
- Pharmaceuticals
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach Volume Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol-Myers Squibb(BMS)
Merck
Roche
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Melanoma treatment
Bladder cancer treatment
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 PD-1 inhibitors
1.2.1.2 PD-L1 inhibitors
1.2.1.3 CTLA-4 inhibitors
1.2.2 by Application
1.2.2.1 Melanoma treatment
1.2.2.2 Bladder cancer treatment
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PD-1 inhibitors Market, 2011-2016
4.1.2 PD-L1 inhibitors Market, 2011-2016
4.1.3 CTLA-4 inhibitors Market, 2011-2016
4.2 Market Forecast
4.2.1 PD-1 inhibitors Market Forecast, 2017-2022
4.2.2 PD-L1 inhibitors Market Forecast, 2017-2022
4.2.3 CTLA-4 inhibitors Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Melanoma treatment Market, 2011-2016
5.1.2 Bladder cancer treatment Market, 2011-2016
5.1.3 Others Market, 2011-2016
5.2 Market Forecast
5.2.1 Melanoma treatment Market Forecast, 2017-2022
5.2.2 Bladder cancer treatment Market Forecast, 2017-2022
5.2.3 Others Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Bristol-Myers Squibb(BMS)
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Merck
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Roche
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Checkpoint Inhibitors for Treating Cancer
Table Products Segment of Checkpoint Inhibitors for Treating Cancer
Table PD-1 inhibitors Overview
Table PD-L1 inhibitors Overview
Table CTLA-4 inhibitors Overview
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2011-2022 (USD Million)
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Melanoma treatment Overview
Table Bladder cancer treatment Overview
Table Others Overview
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2011-2022 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2011-2022 (USD Million)
Table Cost of Checkpoint Inhibitors for Treating Cancer
Table Market Dynamics
Table Policy of Checkpoint Inhibitors for Treating Cancer
Table GDP of Major Countries
Table PD-1 inhibitors CAGR by Revenue and Volume, 2011-2016
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2011-2016
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2011-2016
Table PD-1 inhibitors CAGR by Revenue and Volume, 2012-2022
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2012-2022
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2012-2022
Table Melanoma treatment CAGR by Revenue and Volume, 2011-2016
Table Bladder cancer treatment CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
Lisst Of Figures
Figure Checkpoint Inhibitors for Treating Cancer Picture
Figure Industry Chain Structure of Checkpoint Inhibitors for Treating Cancer
Figure SWOT of Checkpoint Inhibitors for Treating Cancer
Figure PD-1 inhibitors Market Size and Growth, 2011-2016 (USD Million)
Figure PD-1 inhibitors Market Size and Growth, 2011-2016 (in Volume)
Figure PD-L1 inhibitors Market Size and Growth, 2011-2016 (USD Million)
Figure PD-L1 inhibitors Market Size and Growth, 2011-2016 (in Volume)
Figure CTLA-4 inhibitors Market Size and Growth, 2011-2016 (USD Million)
Figure CTLA-4 inhibitors Market Size and Growth, 2011-2016 (in Volume)
Figure PD-1 inhibitors Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure PD-1 inhibitors Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Melanoma treatment Market Size and Growth, 2011-2016 (USD Million)
Figure Melanoma treatment Market Size and Growth, 2011-2016 (in Volume)
Figure Bladder cancer treatment Market Size and Growth, 2011-2016 (USD Million)
Figure Bladder cancer treatment Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Melanoma treatment Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Melanoma treatment Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Bladder cancer treatment Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Bladder cancer treatment Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Checkpoint Inhibitors for Treating Cancer Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
